Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease
Open Access
- 1 August 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 14 (8), 1948-1955
- https://doi.org/10.1093/ndt/14.8.1948
Abstract
Background. Cardiac troponin T (cTnT) is a highly sensitive marker for the detection of myocardial damage. However, patients maintained on chronic dialysis often have increased serum cTnT concentrations without evidence of acute myocardial injury. The reason for this is unclear. In chronic haemodialysis patients, elevated plasma concentrations of big endothelin-1 (big ET-1) and endothelin-1 (ET-1) have been reported which may be associated with ischaemic heart disease. The aim of the present study was to investigate possible associations between cTnT, big ET-1, ET-1, other cardiac markers and cardiac disease in dialysis patients. Methods. Thirty-six haemodialysis (HD) patients and 26 peritoneal dialysis (PD) patients without symptoms of acute myocardial ischaemia were investigated. In all patients, serum concentrations of cTnT (2nd generation ELISA), cardiac troponin I (TnI) (Opus, Behring), creatine kinase MB (CKMB) mass and creatine kinase (CK) were determined, in HD patients before and after dialysis. Additionally, in HD patients, plasma ET-1 and big ET-1 were measured. In 27 HD patients, left ventricular mass index (LVMI) was determined. Patients with ischaemic heart disease (IHD) were compared with non-IHD patients. Results. Serum cTnT was elevated (≥0.10 μg/l) in 20 of 36 HD patients and in eight of 26 PD patients. cTnI was elevated (≥0.5 μg/l) in four of 62 dialysis patients. HD+PD patients with IHD showed higher cTnT than HD+PD patients without IHD, and ET-1 concentrations were higher in HD patients with than without IHD. In HD patients, there was a positive correlation between cTnT and big ET-1. In HD patients with left ventricular hypertrophy (LVH), serum cTnT, CKMB mass and post-dialysis plasma big ET-1 were higher than in patients with normal LVMI. Furthermore there was a positive correlation between cTnT levels and LVMI. Conclusion. These findings suggest that circulating cTnT may reflect left ventricular hypertrophy and/or myocardial ischaemia in dialysis patients, and indicate that ET-1 and big ET-1 might be associated with these conditions.Keywords
This publication has 23 references indexed in Scilit:
- Role of Endogenous Endothelin in Chronic Heart FailureCirculation, 1997
- Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: A 1-year outcomes analysisAmerican Journal of Kidney Diseases, 1997
- Long‐lasting coronary vasoconstrictor effects and myocardial uptake of endothelin‐1 in humansActa Physiologica Scandinavica, 1997
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaNew England Journal of Medicine, 1996
- Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelinEuropean Journal of Pharmacology, 1995
- Metabolism of Big endothelin-1 (1–38) and (22–38) in the human circulation in relation to production of endothelin-1 (1–21)Regulatory Peptides, 1995
- INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1989
- PLASMA ENDOTHELIN LEVELS IN PATIENTS WITH URAEMIAThe Lancet, 1989
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986
- Dialysis-associated ischemic heart disease: Insights from coronary angiographyKidney International, 1984